Influence of the Short-term Intake of High Doses of Solifenacin and Trospium on Cognitive Function and Health-Related Quality of Life in Older Women With Urinary Incontinence

  

Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report

Katherine L. Dengler, Rachel A. High, Daniela C. Moga, Jacqueline Zillioux, Adrian Wagg, Catherine E. DuBeau, Mary F. Ackenbom, Marianna Alperin, Chantale Dumoulin, Lori A. Birder, Donna Mazloomdoost, H. Henry Lai, Vivian W. Sung, Shelly L. Gray, Tatiana

Urogynecology.2023; 29(1S): S1.     CrossRef

Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment

Tatiana V.D. Sanses, Jacqueline Zillioux, Rachel A. High, Katherine L. Dengler, Mary F. Ackenbom, Catherine E. DuBeau, Marianna Alperin, Adrian Wagg, Lori A. Birder, Chantale Dumoulin, Tamara Bavendam

Urogynecology.2023; 29(1S): S20.     CrossRef

Anticholinergic Use for OAB in the Older Woman: An Update

Berkley Davis, Katherina Chen, Olivia Markert, Jacqueline Zillioux

Current Geriatrics Reports.2023; 12(2): 13.     CrossRef

Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults

Akvile Stoniute, Priya Madhuvrata, Madeleine Still, Evelyn Barron-Millar, Ghulam Nabi, Muhammad Imran Omar

Cochrane Database of Systematic Reviews.2023;[Epub]     CrossRef

Treatment of bladder dysfunction with solifenacin: is there a risk of dementia or cognitive impairment?

L.P. Dantas, A.R.C.C. Forte, B.C. Lima, C.N.S. Sousa, E.C. Vasconcelos, P.H.C. Lessa, R.F. Vieira, M.C.A. Patrocínio, S.M.M. Vasconcelos

Brazilian Journal of Medical and Biological Research.2022;[Epub]     CrossRef

Combination and Novel Pharmacologic Agents for OAB

Whitney Clearwater, Farzaan Kassam, Arshia Aalami Harandi, Christopher F. Tenggardjaja, Nitya Abraham

Current Urology Reports.2022; 23(7): 129.     CrossRef

SUFU white paper on overactive bladder anticholinergic medications and dementia risk

Jacqueline Zillioux, Blayne Welk, Anne M. Suskind, E. Ann Gormley, Howard B. Goldman

Neurourology and Urodynamics.2022; 41(8): 1928.     CrossRef

The cognitive effect of anticholinergics for patients with overactive bladder

Blayne Welk, Kathryn Richardson, Jalesh N. Panicker

Nature Reviews Urology.2021; 18(11): 686.     CrossRef

Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta‐3 agonist: a population‐based cohort study

Blayne Welk, Eric McArthur

BJU International.2020; 126(1): 183.     CrossRef

Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo

Rachel A. High, Jill M. Danford, Zhaoyue Shi, Christof Karmonik, Thomas J. Kuehl, Erin T. Bird, Rose Khavari

Contemporary Clinical Trials Communications.2020; 19: 100621.     CrossRef

Alzheimer's disease and related dementias risk: Comparing users of non‐selective and M3‐selective bladder antimuscarinic drugs

Douglas Barthold, Zachary A. Marcum, Shelly L. Gray, Julie Zissimopoulos

Pharmacoepidemiology and Drug Safety.2020; 29(12): 1650.     CrossRef

Current Overview of Surgical Options for Female Stress Urinary Incontinence

Aram Kim, Sehwan Kim, Hyeong Gon Kim

International Neurourology Journal.2020; 24(3): 222.     CrossRef

Treatment of Overactive Bladder in the Frail Patient

Sage Vincent, Anthony Tokarski, Alana Murphy

Current Bladder Dysfunction Reports.2020; 15(4): 386.     CrossRef

Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB

Kirill Kosilov, Irina Kuzina, Vladimir Kuznetsov, Ekaterina Kosilova

European Journal of Obstetrics & Gynecology and Reproductive Biology: X.2019; 4: 100086.     CrossRef

Cognitive and mood side effects of lower urinary tract medication

A. Elif Muderrisoglu, Klaus F. Becher, Stephan Madersbacher, Martin C. Michel

Expert Opinion on Drug Safety.2019; 18(10): 915.     CrossRef